Treatments for Ovarian Cancer or Attractive Returns on Investment
Received Date: Jul 01, 2023 / Published Date: Jul 31, 2023
Abstract
Several clinical and scientific factors have made therapeutic innovation in ovarian cancer challenging. An asymptomatic early-stage presentation makes screening for the disease difficult. As a result, 70% of patients are diagnosed with advanced stage disease. In addition, the heterogeneity of tumour subtypes in ovarian cancer poses considerable scientific challenge to its treatment.
Keywords: Shots-on-goal; Cancer-specific portfolio; Benefits of diversification; Mega fund; Economic value; Calibrated correlations;
Citation: Thampi V (2023) Treatments for Ovarian Cancer or Attractive Returns onInvestment. Adv Cancer Prev 7: 178. Doi: 10.4172/2472-0429.1000178
Copyright: © 2023 Thampi V. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.
Share This Article
Recommended Conferences
7th International Conference on Anti-Cancer Drugs & Therapies
Vancouver, Canada
42nd Global Conference on Nursing Care & Patient Safety
Toronto, CanadaRecommended Journals
Open Access Journals
Article Tools
Article Usage
- Total views: 398
- [From(publication date): 0-2023 - Nov 21, 2024]
- Breakdown by view type
- HTML page views: 330
- PDF downloads: 68
